跳至主要内容
临床试验/KCT0005353
KCT0005353招募中未知

sefulness of heart rate variability (HRV) as non-invasive objective parameters for predicting the occurrence of chemotherapy-induced peripheral neuropathy (CIPN) in gastrointestinal cancer patients precribed chemotherapy

niversity of Ulsan0 个研究点目标入组 100 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational Study

入排标准

年龄范围
18(Year) 至 0No Limit(—)
性别
All

入选标准

  • 1) Adults over 18 years old
  • 2) Histologically confirmed cancer patients
  • 3) Eastern Cooperative Oncology Group (ECOG) evaluation performance is = 1
  • 4) Patients who are prescribed chemotherapy including platinum, paclitaxel, docetaxel, and vinca alkaloid
  • 5) Patients who understand the purpose of the study and can consent in writing without impairment of cognitive function

排除标准

  • 1) Patients with previous history of chemotherapy
  • 2) Patients with diseases that affect other autonomic neuropathy, such as diabetic neuropathy, Parkinson's disease, vitamin B12 deficiency
  • 3) Patients with a history of hospitalization for acute medical history within the last 1 month

研究者

发起方
niversity of Ulsan

相似试验